Orthopedic Biomaterials Market Will Reach USD 32.2 Billion by 2030

The global orthopedic biomaterials market is projected to be worth USD 32.2 billion by 2030, growing at a CAGR of 9.5%. In the recent years, the reconstructive joint replacements category had the largest revenue share of 4.02 billion, and the category is also projected to advance at a substantial CAGR, of 9.2%, during the projection period. This is mainly due to the occurrence of severe joint injury and late-stage osteoarthritis is quickly growing.

In the recent years, the non-metal category, containing of polymers and ceramics, had the significant share, of 59.7%, and the category is also projected to experience the higher CAGR, of 9.9%, during the projection period. This can be credited to the growing utilization of ceramics in hard tissue restoration in numerous procedures, and also the extensive utilization of polymers as load-bearing and bone cement surfaces in total joint arthroplasties. Furthermore, the growing volume of spine operations and interbody fusion procedures will boost the usage of non-metallic orthopedic biomaterials in the near future.

The surge in the load of musculoskeletal issues is expected to fuel the orthopedic biomaterials market development. Musculoskeletal illnesses are the main reason of disability worldwide, according to research, with such disabilities impacting 20–30% of the populace. Swelling, fractures and soreness in the joints, tendons and ligaments are common musculoskeletal issues that result in limited mobility.

Industry key players are concentrating on providing the utmost quality of orthopedic biomaterial treatments and goods, to reduce the treatment expanse and requirement for retreatment for patients. Additionally, the improvements in the biomaterial tech have augmented the success rate of orthopedic operations throughout the globe. The existence of huge businesses in the market plays a substantial role in refining the results for patients with bone-and-joint issues, at the same time support these businesses enlarge their worldwide footprint.

In the recent years, North America dominated the market, and the region is also projected to advance at an attractive CAGR in the coming future. This can be credited to the surge in the count of patients experiencing knee reconstruction and replacement and other treatments on their joints.